
|Articles|April 8, 2008
GlaxoSmithKline's Rotarix gets regulatory green light
GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.
Advertisement
Treatments to prevent rotavirus-caused gastroenteritis will soon gain an addition now that a new vaccine has been approved by the Food & Drug Administration.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































